Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1969 2
1971 1
1974 1
1975 6
1976 4
1977 2
1978 3
1979 3
1980 10
1981 3
1982 11
1983 13
1984 14
1985 8
1986 13
1987 8
1988 13
1989 14
1990 10
1991 15
1992 16
1993 12
1994 10
1995 18
1996 14
1997 22
1998 22
1999 25
2000 11
2001 27
2002 40
2003 37
2004 34
2005 30
2006 49
2007 45
2008 49
2009 60
2010 68
2011 55
2012 67
2013 53
2014 68
2015 73
2016 99
2017 95
2018 109
2019 130
2020 134
2021 166
2022 160
2023 141
2024 198
2025 185

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,260 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for pi cf
Search for Pio CF instead (1 results)
Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient.
Cellucci T, Van Mater H, Graus F, Muscal E, Gallentine W, Klein-Gitelman MS, Benseler SM, Frankovich J, Gorman MP, Van Haren K, Dalmau J, Dale RC. Cellucci T, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Jan 17;7(2):e663. doi: 10.1212/NXI.0000000000000663. Print 2020 Mar. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 31953309 Free PMC article.
New knowledge on anti-IgLON5 disease.
Gaig C, Sabater L. Gaig C, et al. Curr Opin Neurol. 2024 Jun 1;37(3):316-321. doi: 10.1097/WCO.0000000000001271. Epub 2024 Apr 1. Curr Opin Neurol. 2024. PMID: 38563128 Free PMC article. Review.
Second, low levels of neurofilament light chain in serum and cerebrospinal fluid of patients at disease onset could be a predictor of immunotherapy response. ...
Second, low levels of neurofilament light chain in serum and cerebrospinal fluid of patients at disease onset could be a predi …
Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis.
Guasp M, Giné-Servén E, Maudes E, Rosa-Justicia M, Martínez-Hernández E, Boix-Quintana E, Bioque M, Casado V, Módena-Ouarzi Y, Guanyabens N, Muriana D, Sugranyes G, Pacchiarotti I, Davi-Loscos E, Torres-Rivas C, Ríos J, Sabater L, Saiz A, Graus F, Castro-Fornieles J, Parellada E, Dalmau J. Guasp M, et al. Neurology. 2021 Jul 6;97(1):e61-e75. doi: 10.1212/WNL.0000000000012191. Epub 2021 May 12. Neurology. 2021. PMID: 33980703
GAD antibodies in neurological disorders - insights and challenges.
Graus F, Saiz A, Dalmau J. Graus F, et al. Nat Rev Neurol. 2020 Jul;16(7):353-365. doi: 10.1038/s41582-020-0359-x. Epub 2020 May 26. Nat Rev Neurol. 2020. PMID: 32457440 Review.
Given that stiff-person syndrome is usually autoimmune, the presence of GAD antibodies in the cerebrospinal fluid is sufficient to confirm a pathogenic link with GAD autoimmunity. However, for cerebellar ataxia, epilepsy and other syndromes with different aetiologie …
Given that stiff-person syndrome is usually autoimmune, the presence of GAD antibodies in the cerebrospinal fluid is sufficien …
Clinical manifestations of the anti-IgLON5 disease.
Gaig C, Graus F, Compta Y, Högl B, Bataller L, Brüggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Martí MJ, Montojo T, Pérez-Pérez J, Puertas I, Seitz C, Simabukuro M, Téllez N, Wandinger KP, Iranzo A, Ercilla G, Sabater L, Santamaría J, Dalmau J. Gaig C, et al. Neurology. 2017 May 2;88(18):1736-1743. doi: 10.1212/WNL.0000000000003887. Epub 2017 Apr 5. Neurology. 2017. PMID: 28381508 Free PMC article.
Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial hypotension.
Cheema S, Anderson J, Angus-Leppan H, Armstrong P, Butteriss D, Carlton Jones L, Choi D, Chotai A, D'Antona L, Davagnanam I, Davies B, Dorman PJ, Duncan C, Ellis S, Iodice V, Joy C, Lagrata S, Mead S, Morland D, Nissen J, Pople J, Redfern N, Sayal PP, Scoffings D, Secker R, Toma AK, Trevarthen T, Walkden J, Beck J, Kranz PG, Schievink W, Wang SJ, Matharu MS. Cheema S, et al. J Neurol Neurosurg Psychiatry. 2023 Oct;94(10):835-843. doi: 10.1136/jnnp-2023-331166. Epub 2023 May 5. J Neurol Neurosurg Psychiatry. 2023. PMID: 37147116 Free PMC article.
BACKGROUND: We aimed to create a multidisciplinary consensus clinical guideline for best practice in the diagnosis, investigation and management of spontaneous intracranial hypotension (SIH) due to cerebrospinal fluid leak based on current evidence and consensus fro …
BACKGROUND: We aimed to create a multidisciplinary consensus clinical guideline for best practice in the diagnosis, investigation and manage …
Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies.
Dilcher R, Wall S, Groß M, Katzdobler S, Wagemann O, Palleis C, Weidinger E, Fietzek U, Bernhardt A, Kurz C, Ferschmann C, Scheifele M, Zaganjori M, Gnörich J, Bürger K, Janowitz D, Rauchmann BS, Stöcklein S, Bartenstein P, Villemagne V, Seibyl J, Sabri O, Barthel H, Perneczky R, Schöberl F, Zwergal A, Höglinger GU, Levin J, Franzmeier N, Brendel M. Dilcher R, et al. Alzheimers Dement. 2024 Oct;20(10):6896-6909. doi: 10.1002/alz.14185. Epub 2024 Sep 12. Alzheimers Dement. 2024. PMID: 39263969 Free PMC article.
METHODS: We cross-sectionally assessed combinations of cerebrospinal fluid measures (CSF p-tau(181) and t-tau) and (18)F-PI-2620 tau-positron emission tomography (PET) in patients with AD (n = 64), clinically suspected 4RTs (progressive supranuclear palsy or …
METHODS: We cross-sectionally assessed combinations of cerebrospinal fluid measures (CSF p-tau(181) and t-tau) and (18)F-PI …
Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.
Armangue T, Spatola M, Vlagea A, Mattozzi S, Cárceles-Cordon M, Martinez-Heras E, Llufriu S, Muchart J, Erro ME, Abraira L, Moris G, Monros-Giménez L, Corral-Corral Í, Montejo C, Toledo M, Bataller L, Secondi G, Ariño H, Martínez-Hernández E, Juan M, Marcos MA, Alsina L, Saiz A, Rosenfeld MR, Graus F, Dalmau J; Spanish Herpes Simplex Encephalitis Study Group. Armangue T, et al. Lancet Neurol. 2018 Sep;17(9):760-772. doi: 10.1016/S1474-4422(18)30244-8. Epub 2018 Jul 23. Lancet Neurol. 2018. PMID: 30049614 Free PMC article.
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study.
Dage JL, Eloyan A, Thangarajah M, Hammers DB, Fagan AM, Gray JD, Schindler SE, Snoddy C, Nudelman KNH, Faber KM, Foroud T, Aisen P, Griffin P, Grinberg LT, Iaccarino L, Kirby K, Kramer J, Koeppe R, Kukull WA, La Joie R, Mundada NS, Murray ME, Rumbaugh M, Soleimani-Meigooni DN, Toga AW, Touroutoglou A, Vemuri P, Atri A, Beckett LA, Day GS, Graff-Radford NR, Duara R, Honig LS, Jones DT, Masdeu JC, Mendez MF, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Womack KB, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG; LEADS Consortium. Dage JL, et al. Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S115-S125. doi: 10.1002/alz.13399. Epub 2023 Jul 25. Alzheimers Dement. 2023. PMID: 37491668 Free PMC article.
INTRODUCTION: One goal of the Longitudinal Early Onset Alzheimer's Disease Study (LEADS) is to define the fluid biomarker characteristics of early-onset Alzheimer's disease (EOAD). METHODS: Cerebrospinal fluid (CSF) concentrations of Abeta1-40, Abeta1-42, tot …
INTRODUCTION: One goal of the Longitudinal Early Onset Alzheimer's Disease Study (LEADS) is to define the fluid biomarker characteris …
2,260 results